Skip to content
OpenCapital
Get started

Cerus CERS Enterprise value

Enterprise value at other companies

CorMedix logo
CorMedixCRMD
$774.78M+71.7%
Haemonetics logo
HaemoneticsHAE
$3.65B-12.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$6.54B+130%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$3.8B-21.5%
ADMA Biologics logo
ADMA BiologicsADMA
$2.21B-52.5%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%—
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Calculated from Cerus’s reported figures.

$349.8Mmarket cap+$45.0Mtotal debt−$27.9Mcash and equivalents=$366.86M

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's enterprise value?
Cerus (CERS) reported enterprise value of $366.86M in Q1 2026.
How has Cerus's enterprise value changed year-over-year?
Cerus's enterprise value increased by 15.3% year-over-year, from $318.12M to $366.86M.
What is the long-term trend for Cerus's enterprise value?
Over 5 years (2020 to 2025), Cerus's enterprise value has grown at a -18.8% compound annual growth rate (CAGR), from $1.21B to $429.34M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.